Labcorp outlines strategic approaches to biomarker integration across oncology development, highlighting its role in patient stratification, trial acceleration, and regulatory streamlining. The company emphasizes the importance of operational standardization, sample-sparing platforms, and comprehensive data outputs to manage multi-site complexities. These innovations support both exploratory research and clinical trials, facilitating precision medicine advances and therapy differentiation.